168 related articles for article (PubMed ID: 29687854)
1. Plasma long non-coding RNAs (lncRNAs) serve as potential biomarkers for predicting breast cancer.
Jiao ZY; Tian Q; Li N; Wang HB; Li KZ
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1994-1999. PubMed ID: 29687854
[TBL] [Abstract][Full Text] [Related]
2. Identification of Differentially Expressed Plasma lncRNAs As Potential Biomarkers for Breast Cancer.
Wang M; Liu H; Wu W; Zhao J; Song G; Chen X; Wang R; Shao C; Li J; Wang H; Wang Q; Feng X
Clin Breast Cancer; 2022 Feb; 22(2):e135-e141. PubMed ID: 34119428
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study.
Xu N; Chen F; Wang F; Lu X; Wang X; Lv M; Lu C
Tumour Biol; 2015 Sep; 36(10):7659-65. PubMed ID: 25929808
[TBL] [Abstract][Full Text] [Related]
4. Serum Long Non-Coding RNAs PVT1, HOTAIR, and NEAT1 as Potential Biomarkers in Egyptian Women with Breast Cancer.
El-Fattah AAA; Sadik NAH; Shaker OG; Mohamed Kamal A; Shahin NN
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670447
[TBL] [Abstract][Full Text] [Related]
5. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
Malih S; Saidijam M; Malih N
Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
[TBL] [Abstract][Full Text] [Related]
6. [Long non-coding RNA HOTAIR in plasma as a potential biomarker for breast cancer diagnosis].
Zhang KJ; Zhang Y; Luo ZL; Liu L; Yang J; Wu LC; Yu SS; Liu JB
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):488-92. PubMed ID: 27113175
[TBL] [Abstract][Full Text] [Related]
7. The use of Human Inflammatory Response and Autoimmunity RT2 lncRNA PCR Array for plasma examination in breast cancer patients prior to therapy.
Sterbova M; Pazourkova E; Santorova-Pospisilova S; Zednikova I; Tesarova P; Korabecna M
Neoplasma; 2019 Jul; 66(4):641-646. PubMed ID: 30943749
[TBL] [Abstract][Full Text] [Related]
8. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
[TBL] [Abstract][Full Text] [Related]
9. Circulating LncRNAs landscape as potential biomarkers in breast cancer.
Pourramezan Z; Attar FA; Yusefpour M; Azizi M; Oloomi M
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1722. PubMed ID: 36274054
[TBL] [Abstract][Full Text] [Related]
10. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
[TBL] [Abstract][Full Text] [Related]
11. Plasma Exosomal Long Non-Coding RNAs Serve as Biomarkers for Early Detection of Colorectal Cancer.
Hu D; Zhan Y; Zhu K; Bai M; Han J; Si Y; Zhang H; Kong D
Cell Physiol Biochem; 2018; 51(6):2704-2715. PubMed ID: 30562751
[TBL] [Abstract][Full Text] [Related]
12. [Circulating long noncoding RNAs as biomarkers in tumor diagnosis].
Jiang N; Tian H; Pan J; Gong Z
Sheng Wu Gong Cheng Xue Bao; 2017 Jun; 33(6):910-922. PubMed ID: 28895353
[TBL] [Abstract][Full Text] [Related]
13. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.
Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J
Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794
[TBL] [Abstract][Full Text] [Related]
14. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
Han L; Ma P; Liu SM; Zhou X
Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
[TBL] [Abstract][Full Text] [Related]
15. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer.
Zhou X; Yin C; Dang Y; Ye F; Zhang G
Sci Rep; 2015 Jun; 5():11516. PubMed ID: 26096073
[TBL] [Abstract][Full Text] [Related]
16. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
17. Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer.
Özgür E; Ferhatoğlu F; Şen F; Saip P; Gezer U
Cancer Biomark; 2020; 27(1):11-17. PubMed ID: 31640083
[TBL] [Abstract][Full Text] [Related]
18. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication.
Wang J; Ye C; Xiong H; Shen Y; Lu Y; Zhou J; Wang L
Oncotarget; 2017 Jan; 8(3):5508-5522. PubMed ID: 27732939
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology.
Zhang Z; Weaver DL; Olsen D; deKay J; Peng Z; Ashikaga T; Evans MF
J Clin Pathol; 2016 Jan; 69(1):76-81. PubMed ID: 26323944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
